Key result
A clinical pharmaco-proteomic approach may improve patient selection, ensure precise clinical phenotyping, and individualize treatment for complex neurovascular diseases.
Population
Patients with neurovascular diseases, specifically ischemic stroke, post-cardiac arrest syndrome, and patent…
Design
Review
Authors
Loading...
Hypothesis-generating for pharmaco-proteomics in neurovascular disease; prospective trials needed before clinical adoption.
Pharmaco-proteomics offers a promising systemic approach to improve patient selection and individualize therapies for complex neurovascular diseases like ischemic stroke and post-cardiac arrest syndrome.
Ning et al. (2013) conducted a review in Neurovascular disease. Pharmaco-proteomic approach was evaluated. A clinical pharmaco-proteomic approach may improve patient selection, ensure precise clinical phenotyping, and individualize treatment for complex neurovascular diseases.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: